Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug development

By Duong MyNgan   Nicholls Stephen J  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 7, 2009-07 ,pp. : 753-761

Informa Healthcare

Access to resources Recommend Favorite

Lipid-Modifying Therapy and Attainment of Cholesterol Goals in Hungary: The Return on Expenditure Achieved for Lipid Therapy (REALITY) Study

By Paragh György  

Clinical Drug Investigation, Vol. 27, Iss. 9, 2007-01 ,pp. : 647-660

Adis International

Access to resources Recommend Favorite

Fenofibrate: A Review of its Lipid-Modifying Effects in Dyslipidemia and its Vascular Effects in Type 2 Diabetes Mellitus

By Keating Gillian M.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 4, 2011-08 ,pp. : 227-247

Adis International

Access to resources Recommend Favorite

Attenuation of Rate of Change in Carotid Intima-Media Thickness by Lipid-Modifying Drugs: Impact on Clinical Outcomes

By Peters Sanne A.E.   Ruijter Hester M. den   Bots Michiel L.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 4, 2011-08 ,pp. : 253-263

Adis International

Access to resources Recommend Favorite

Cholesterol and plasma lipid modifying patents

By Suckling K.E.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 11, 1998-11 ,pp. : 1415-1423

Informa Healthcare

Access to resources Recommend Favorite